Formulation, Characterization and In vitro Cytotoxicity of 5-Fluorouracil Loaded Polymeric Electrospun Nanofibers for the Treatment of Skin Cancer

Author(s): Gayatri Patel*, Bindu K.N. Yadav.

Journal Name: Recent Patents on Nanotechnology

Volume 13 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The purpose of this study was to formulate, characterize and conduct in vitro cytotoxicity of 5-fluorouracil loaded polymeric electrospun nanofibers for the treatment of skin cancer. The patents on electrospun nanofibers (US9393216B2), (US14146252), (WO2015003155A1) etc. helped in the selection of polymers and method for the preparation of nanofibers.

Methods: In the present study, the fabrication of nanofibers was done using a blend of chitosan with polyvinyl alcohol and processed using the electrospinning technique. 5-fluorouracil with known chemotherapeutic potential in the treatment of skin cancer was used as a drug carrier. 24-1 fractional factorial screening design was employed to study the effect of independent variables like the concentration of the polymeric solution, applied voltage (kV), distance (cm), flow rate (ml / hr) on dependent variables like % entrapment efficiency and fiber diameter.

Results: Scanning electron microscopy was used to characterize fiber diameter and morphology. Results showed that the fiber diameter of all batches was found in the range of 100-200 nm. The optimized batch results showed the fiber diameter of 162.7 nm with uniform fibers. The tensile strength obtained was 190±37 Mpa. Further in vitro and ex vivo drug release profile suggested a controlled release mechanism for an extended period of 24 hr. The 5-fluorouracil loaded electrospun nanofibers were found to decrease cell viability up to ≥50% over 24 hr, with the number of cells dropping by ~ 10% over 48 hr. As the cell viability was affected by the release of 5-fluorouracil, we believe that electrospun nanofibers are a promising drug delivery system for the treatment of Basal Cell Carcinoma (BCC) skin cancer.

Conclusion: These results demonstrate the possibility of delivering 5-Fluorouracil loaded electrospun nanofiber to skin with enhanced encapsulation efficiency indicating the effectiveness of the formulation for the treatment of basal cell carcinoma type of skin cancer.

Keywords: Skin cancer, biopolymer, electrospinning, nanofibers, morphology, drug delivery, patents.

[1]
Kim I, He YY. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis 2014; 1(2): 188-98.
[2]
Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.In: Sunlight, Vitamin D and Skin Cancer. 2nd ed. New York: Springer 2008; pp. 162-78.
[3]
Brady MS, Kaushal A, Ko C, Flaherty K, Branch RO. Melanoma and other skin cancers. Cancer Manage 2011; 14: 1-32.
[4]
Ikoba U, Peng H, Li H, Miller C, Yu C, Wang Q. Nanocarriers in therapy of infectious and inflammatory diseases. Nanoscale 2015; 7(10): 4291-305.
[5]
Song F, Li X, Wang Q, Liao L, Zhang C. Nanocomposite hydrogels and their applications in drug delivery and tissue engineering. J Biomed Nanotechnol 2015; 11(1): 40-52.
[6]
Jose A, Labala S, Venuganti VV. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. J Drug Target 2017; 25(4): 330-41.
[7]
Miyata T, Nakamae K, Hoffman AS, Kanzaki Y. Stimuli‐sensitivities of hydrogels containing phosphate groups. Macromol Chem Phys 1994; 195(4): 1111-20.
[8]
Hafeez A, Kazmi I. Dacarbazine nanoparticle topical delivery system for the treatment of melanoma. Sci Rep 2017; 7(1): 16517.
[9]
Khallaf RA, Salem HF, Abdelbary A. 5-Fluorouracil shell-enriched Solid Lipid Nanoparticles (SLN) for effective skin carcinoma treatment. Drug Deliv 2016; 23(9): 3452-60.
[10]
Gupta A, Singh S, Kotla NG, Webster TJ. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomed 2015; 10: 171.
[11]
Hanahan D, Bergers G, Bergsland E. Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 2000; 105(8): 1045-7.
[12]
Marshall JL. Maximum-tolerated dose, optimum biologic dose, or optimum clinical value: Dosing determination of cancer therapies. J Clin Oncol 2012; 30(23): 2815-6.
[13]
Fang J, Niu H, Lin T, Wang X. Applications of electrospun nanofibers. Chinese Sci Bull 2008; 53(15): 2265.
[14]
Liu YQ, Feng JW, Zhang CC, Teng Y, Liu Z, He JH. Air permeability of nanofiber membrane with hierarchical structure. Therm Sci 2018; 22: 1637-43.
[15]
Zhang J, Duan Y, Wei D, et al. Co electrospun fibrous scaffold-adsorbed DNA for substrate mediated gene delivery. J Biomed Mater Res Part A 2011; 96(1): 212-20.
[16]
Cao H, Jiang X, Chai C, Chew SY. RNA interference by nanofiber-based siRNA delivery system. J Control Release 2010; 144(2): 203-12.
[17]
Jayaraman K, Kotaki M, Zhang Y, Mo X, Ramakrishna S. Recent advances in polymer nanofibers. J Nanosci Nanotechnol 2004; 4(1-2): 52-65.
[18]
Baji A, Mai YW, Wong SC, Abtahi M, Chen P. Electrospinning of polymer nanofibers: Effects on oriented morphology, structures and tensile properties. Comp Sci Technol 2010; 70(5): 703-18.
[19]
Dong Z, Kennedy SJ, Wu Y. Electrospinning materials for energy-related applications and devices. J Power Sources 2011; 196(11): 4886-904.
[20]
Subbiah T, Bhat GS, Tock RW, Parameswaran S, Ramkumar SS. Electrospinning of nanofibers. J Appl Polym Sci 2005; 96(2): 557-69.
[21]
Garg K, Bowlin GL. Electrospinning jets and nanofibrous structures. Biomicrofluidics 2011; 5(1)013403
[22]
Li D, Xia Y. Electrospinning of nanofibers: Reinventing the wheel? Adv Mater 2004; 16(14): 1151-70.
[23]
Bhardwaj N, Kundu SC. Electrospinning: A fascinating fiber fabrication technique. Biotechnol Adv 2010; 28(3): 325-47.
[24]
Mengistu LS, Bossard F, Rinaudo M. Preparation of pure and stable chitosan nanofibers by electrospinning in the presence of poly (ethylene oxide). Int J Mol Sci 2016; 17(11): 1790.
[25]
Arkoun M, Daigle F, Heuzey MC, Ajji A. Antibacterial electrospun chitosan‐based nanofibers: A bacterial membrane perforator. Food Sci Nutr 2017; 5(4): 865-74.
[26]
Peresin MS, Habibi Y, Zoppe JO, Pawlak JJ, Rojas OJ. Nanofiber composites of polyvinyl alcohol and cellulose nanocrystals: Manufacture and characterization. Biomacromolecules 2010; 11(3): 674-81.
[27]
Islam MS, Karim MR. Fabrication and characterization of poly (vinyl alcohol)/alginate blend nanofibers by electrospinning method. Colloids Surf A Physicochem Eng Asp 2010; 366(1-3): 135-40.
[28]
Woodrow KA, Ball C, Blakney A, Krogstad E, Nie H. inventors; University of Washington, assignee. Vaginal matrices: Nanofibers for contraception and prevention of HIV infection. US Patent 9393216 2016
[29]
Yoo HS, Choi JS, Kim Y, Jihyun KA. Chitosan nanofiber for anionic protein drug delivery, method of preparing the same, and pharmaceutical preparation for transmucosal administration comprising the chitosan nanofiber. US Patent 14146252, 2014
[30]
Azzazy HM, Sarhan WA. Bio-compatible apitherapeutic nanofibers. WO Patent 2015003155A1, 2015.
[31]
Finkielsztein S, Vournakis JN. Treatment of disease with poly-nacetylglucosamine nanofibers. US Patent 14210054, 2015.
[32]
Rolandi M, Ruvolo V, Berenson RJ, Ruebel C, Jungho JI. Microstructure- based wound closure devices. US Patent 14408244, 2015
[33]
Laurencin CT, Nair LS, Bhattacharyya S, et al. Allcock HR, Bender JD, Brown PW, Greish YE. Polymeric nanofibers for tissue engineering and drug delivery. US Patent 7235295 2007
[34]
Homayoni H, Ravandi SA, Valizadeh M. Electrospinning of chitosan nanofibers: Processing optimization. Carbohydr Polym 2009; 77(3): 656-61.
[35]
Jia YT, Gong J, Gu XH, Kim HY, Dong J, Shen XY. Fabrication and characterization of poly (vinyl alcohol)/chitosan blend nanofibers produced by electrospinning method. Carbohydr Polym 2007; 67(3): 403-9.
[36]
Reda RI, Wen MM, El-Kamel AH. Ketoprofen-loaded eudragit electrospun nanofibers for the treatment of oral mucositis. Int J Nanomed 2017; 12: 2335.
[37]
Barad M. Design of Experiments (DOE).In: Strategies and Techniques for Quality and Flexibility. 2nd ed. Cham: Springer 2018; pp. 61-79.
[38]
Arnold SF. Design of experiments with MINITAB. Pennsylvania: Minitab 2006; pp. 205-5.
[39]
Wilkinson L. Revising the Pareto chart. The American Statistician. 2006; 60(4): 332-4.
[40]
Schiffman JD, Schauer CL. Cross-linking chitosan nanofibers. Biomacromolecules 2007; 8(2): 594-601.
[41]
Rao M, Song X, Cairns EJ. Nano-carbon/sulfur composite cathode materials with carbon nanofiber as electrical conductor for advanced secondary lithium/sulfur cells. J Power Sources 2012; 205: 474-8.
[42]
Huang ZM, Zhang YZ, Ramakrishna S, Lim CT. Electrospinning and mechanical characterization of gelatin nanofibers. Polymer 2004; 45(15): 5361-8.
[43]
Tungprapa S, Jangchud I, Supaphol P. Release characteristics of four model drugs from drug-loaded electrospun cellulose acetate fiber mats. Polymer 2007; 48(17): 5030-41.
[44]
Modgill V, Garg T, Goyal AK, Rath G. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol 2016; 44(1): 122-7.
[45]
Zhang YL, Zhang ZH, Jiang TY, Lv HX, Zhou JP. Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells. Pharmazie 2013; 68(1): 47-53.
[46]
Cheddadi M, López-Cabarcos E, Slowing K, Barcia E, Fernández-Carballido A. Cytotoxicity and biocompatibility evaluation of a poly (magnesium acrylate) hydrogel synthesized for drug delivery. Int J Pharm 2011; 413(1-2): 126-33.
[47]
Jia YT, Gong J, Gu XH, Kim HY, Dong J, Shen XY. Fabrication and characterization of poly (vinyl alcohol)/chitosan blend nanofibers produced by electrospinning method. Carbohydr Polym 2007; 67(3): 403-9.
[48]
Liu YQ, Zhao L, He JH. Nanoscale multi-phase flow and its application to control nanofiber diameter. Thermal Sci 2018; 22(1A): 43-6.
[49]
Sridhar R, Ravanan S, Venugopal JR, et al. Curcumin-and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: In vitro efficacy evaluation. J Biomater Sci Polym Ed 2014; 25(10): 985-98.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 2
Year: 2019
Page: [114 - 128]
Pages: 15
DOI: 10.2174/1872210513666190314095643
Price: $58

Article Metrics

PDF: 29
HTML: 3
PRC: 1